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Abstract
Background: To evaluate the in vivo corneal changes using in vivo confocal microscopy (IVCM) and anterior
segment optical coherence tomography (AS-OCT) in patients with Fuchs’ dystrophy who underwent Descemet
stripping automated endothelial keratoplasty (DSAEK) and the relationship between these changes and the
postoperative visual recovery up to 1-year follow-up.
Methods: Before DSAEK and 1 day, 3, 6 and 12 months after surgery 31 patients (39 pseudophakic eyes)
underwent a complete ophthalmological evaluation including best corrected visual acuity (BCVA), IVCM
(subepithelial haze, interface haze, graft thickness) and AS-OCT (graft thickness).
Results: Graft thickness measurements by AS-OCT were strongly correlated to those obtained using IVCM at every
follow-up stage (intraclass correlation coefficient = 0.95 to 0.97 between 3 and 12 months, P < 0.001 for all
coefficients). No correlation between BCVA and graft thickness measured by AS-OCT at any follow-up stage was
found, while at 3 and 6 postoperative months the correlations between BCVA and preoperative subepithelial haze
(r = 0.61, P < 0.001 and r = 0.46, P = 0.002), interface haze (r = 0.51, P < 0.001 and r = 0.46, P = 0.003), postoperative
subepithelial haze (r = 0.43, P = 0.004 and r = 0.39, P = 0.001) were significant.
Conclusions: The study confirmed corneal subepithelial haze and interface haze as important factors limiting visual
acuity after DSAEK, while graft thickness was not related to BCVA.
Background
Notwithstanding the growing interest on Descemet
membrane endothelial keratoplasty (DMEK), Descemet
stripping automated endothelial keratoplasty (DSAEK) is
still one of the treatment of choice for Fuchs’ corneal
endothelial dystrophy. This surgical technique allows the
selective replacement of the posterior dysfunctional part
of the cornea, including endothelium, Descemet membrane
and a variable small amount of posterior stroma [1, 2].
This technique has shown several advantages over
penetrating keratoplasty (PK): it has been reported to
cause lower astigmatism, lower suture-related complica-
tions than PK [3–5], fewer high-order corneal aberrations
[6] and a more rapid visual recovery [7, 8]. The majority
of patients actually reach a best corrected visual acuity
(BCVA) of 20/40 or better [3, 7, 8]. Nevertheless, even in
presence of clear grafts, the percentage of patient
achieving a BCVA of 20/20 is relatively small, and it is
also well-known that DSAEK leads to a small hyperopic
shift [9–11], residual corneal aberrations, glare and reduced
contrast sensitivity compared to normal [4, 5, 12–17].
Therefore the debate whether surgical technique, donor
lenticule preparation method, graft characteristics or
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recipient characteristics can affect DSAEK clinical outcome
is still ongoing [13, 14, 18–20]. Specifically, previous studies
analyzed possible correlations between postoperative visual
acuity or visual quality and factors such as recipient
corneal preoperative haze, recipient age, duration of the
disease at the time of surgery, graft thickness, recipient
corneal thickness and densitometry, often obtaining
controversial results [9, 21–24].
Among the most used devices to evaluate these pa-
rameters are anterior segment Optical coherence tom-
ography (AS-OCT) and in vivo confocal microscopy
(IVCM).
AS-OCT is a diagnostic method widely used in oph-
thalmology and a non-invasive useful device in DSAEK
follow-up. It allows to evaluate graft adhesion in the im-
mediate postoperative period and to measure graft and
corneal thickness [25, 26].
IVCM is a non-invasive diagnostic test that allows to
acquire images of all the corneal layers (epithelium,
Bowman’s membrane, stroma, Descemet membrane and
endothelium) and of their cellular components (superficial
and basal cells, nerve fibers, stromal keratocytes, endothe-
lial cells) [27]. It is therefore used in the diagnosis and
follow-up of various corneal diseases. Furthermore the
IVCM is often performed during preoperative evaluations
and postoperative follow-up of corneal transplants and re-
fractive surgery [22–24, 28–30]. To our knowledge, there
isn’t any report in literature evaluating DSAEK outcome
with both AS-OCT and IVCM, analyzing possible correla-
tions between preoperative or postoperative corneal and
graft characteristics and visual outcome.
The purpose of our study was to evaluate the in vivo
corneal changes using white-light IVCM and time do-
main AS-OCT in patients with Fuchs’ endothelial dys-
trophy who underwent DSAEK and the relationship
between these changes and the postoperative visual re-
covery up to 1 year follow-up.
Methods
This prospective cohort study involved 39 pseudophakic
eyes of 31 patients who underwent DSAEK surgery due
to Fuchs’ corneal endothelial dystrophy at the Eye clinic,
Careggi University Hospital of Florence, Italy, between
March 2011 and September 2012. The study followed
the tenets of the Declaration of Helsinki and was ap-
proved by the local ethic committee (Careggi University
Hospital of Florence). All patients signed a surgical in-
formed consent form before DSAEK and an informed
consent for the study.
Exclusion criteria for this study were concurrent eye
pathology as glaucoma, macular/retinal diseases signifi-
cantly affecting visual acuity, amblyopia, optic neuritis,
uveitis, scleritis, ocular infection, pre-existing severe cor-
neal scarring.
Preoperative evaluation
At the preoperative visit all patients underwent a complete
ophthalmological evaluation including best corrected
visual acuity (BCVA, LogMAR), slit lamp biomicro-
scopy, intraocular pressure measurement, fundus oph-
thalmoscopy, white light IVCM (Confoscan 4, Nidek
Technologies, Birmingham, UK) and time domain
AS-OCT (Visante OCT, Carl Zeiss Meditec Inc, Dublin,
California, USA).
IVCM was performed with a 40 X magnification and
the z-ring adapter [31]. Lamp brightness was set at 80 in
all examinations. Images obtained by Confoscan 4 were
approximately 460x345 microns wide.
Before the exam, a drop of topical anesthetic (Benoxinate)
was instilled. The patient was then asked to steadily fixate a
target and IVCM was performed on the central cornea.
The exam lasted approximately 3 min. At the end of the
examination, an antibiotic eye drop (gentamicin 0.3 %) was
administered.
The preoperative subepithelial haze was measured as
the mean between the peak value of LRU (light reflect-
ance units) in the subepithelial area and the values at 25
microns in the endothelial direction and 25 microns in
the epithelial direction. Since at each examination Con-
foscan 4 performed three different scans of the cornea,
three mean values, one for each scan, were obtained and
averaged.
Two trained investigators performed the examination
and one masked investigator selected and analyzed
IVCM and AS-OCT scans.
Surgical technique
All patients underwent DSAEK surgery alone.
All procedures were performed under monitored
anesthesia with peribulbar block.
The posterior lamellar grafts were supplied from the
Cornea Bank of Lucca (Italy), after having been cut by a
microkeratome with a a 350-micron head (Moria SA,
Antony, France).
They were trephinated by the surgeon with a
Hessburg-Barron donor corneal punch (Barron Precision
Instruments, LLC, Grand Blanc, Michigan USA) to a
diameter of 8.25–8.75 mm. All grafts had an endothelial
cell count of at least 2500 cells/mm2. Graft thickness
provided by the Bank was recorded.
The anterior chamber of the eye was then entered
through a 4 mm clear corneal incision, and in order to
prevent the anterior chamber collapse a maintainer was
used. Descemet membrane was stripped from the central
8-8.5 mm diameter. The rolled endothelial graft was
inserted using a Busin glide (Moria Inc, Antony, France)
and a small air bubble that was injected to lift the graft.
After centering the graft, the anterior chamber was
completely filled with an air bubble that after 10 min
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was reduced to about the 80 % of the size of the endo-
thelial graft.
All surgical procedures were performed by the same
skilled surgeon, RM.
Postoperative follow-up
Patients were evaluated 1 day, 1 week, 1 month, 3, 6 and
12 months after surgery. Whereas each visit consisted of
complete ophthalmic examinations, including BCVA
and slit-lamp examination, at 3, 6 and 12 month visits
AS-OCT (graft thickness measurement) and IVCM
(graft thickness, interface haze and subepithelial haze
evaluation) were also performed.
Graft thickness was measured by IVCM by assessing
the distance from the endothelium to the change of re-
flectance that suggests the beginning of donor-recipient
interface, then calculating the mean between the values
obtained in each of the three scans performed by IVCM
at each examination. The donor-recipient interface was
identified as the area where a change in cell morphology
and/or extracellular matrix was detected.
The donor-recipient interface haze, the characteristic
gain in reflectance that may be observed at the border
between the donor graft and the recipient cornea, was
also evaluated by IVCM. It was measured as the mean
between the peak value of LRU at the interface and the
values at 25 microns in the endothelial direction and 25
microns in the epithelial direction; then we averaged the
three mean values obtained, one for each scan.
Postoperative subepithelial haze was measured as
already described in the preoperative evaluation section.
Graft thickness was measured by AS-OCT on a hori-
zontal cross sectional image obtained at the anterior
corneal vertex, using the software-imbedded flap-tool
(high-resolution corneal scan mode).
Statistical analysis
Linear mixed models were used to compare the change
of the covariates of interest (logMAR BCVA, haze and
thickness-related variables) at various follow-up times,
accounting for correlated data using time as a random
slope at the subject level. In order to simultaneously as-
sess the correlation between covariates at different
follow-up times, while accounting for individual correl-
ation, structural equation modeling (SEM) of standard-
ized variables was performed. Intraclass correlation
coefficient (ICC) was used to compare graft thickness
measured by means of AS-OCT and IVCM.
All analyses were carried out using Stata software
(StataCorp 13.1, College Station, TX).
Results were expressed as mean and standard devi-
ation (SD). A value of P < 0.05 was considered statisti-
cally significant.
Results
The mean age of the patients was 73 ± 9.3 years (55 to
81 years).
BCVA gradually improved during the follow-up (Fig. 1
and Table 1): the mean preoperative BCVA was 0.78 log-
MAR (20/120 Snellen) (SD = 0.35 logMAR) and signifi-
cantly increased to 0.13 logMAR (20/25 Snellen) at
1 year (SD = 0.09 logMAR) (P < 0.001).
Graft thickness
Mean graft thickness was 132.3 μ (SD = 32.7 μ) at baseline,
as measured by the Eye Bank using Visante AS-OCT.
During follow-up (Fig. 2a and Table 1), a statistically
significant reduction of graft thickness measured by
AS-OCT compared to the Eye Bank value (P = 0.022 at
3 months, P < 0.001 at 6 and 12 months) was observed.
In comparison with the 3-month value, graft thickness
reduction was not significant at 6 months (P = 0.069),
while it was significant at 1 year (P < 0.001).
Graft thickness measured by IVCM decreased signifi-
cantly at 6 months and 1 year (Fig. 2b and Table 1) com-
pared with the 3-month value (P = 0.026 and P = 0.003,
respectively).
Graft thickness measurements by AS-OCT were
strongly correlated to those obtained using IVCM at any
follow-up stage (ICC = 0.95 to 0.97 between 3 and
12 months, P < 0.001 for all coefficients). IVCM yielded
slightly but significantly thicker measures compared to
AS-OCT at 3 months (5.2 μ, 95 % CI 2.6 to 7.8 μ),
Fig. 1 Best corrected visual acuity (BCVA) significant improvement
up to 1-year after Descemet stripping automated endothelial
keratoplasty for Fuchs’ corneal dystrophy (P < 0.001 at each
postoperative visit vs preoperative value)
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6 months (4.1 μ, 95 % CI 2.7 to 5.5 μ) and 12 months
(3.5 μ, 95%CI 1.3 to 5.7 μ).
In Fig. 3 graft thickness measurement by AS-OCT is
shown.
IVCM corneal haze (subepithelial haze, interface haze)
Preoperative mean subepithelial haze was 133.0 LRU
(SD = 33.3 LRU).
At every follow-up stage a statistically significant
donor-recipient interface haze decrease compared to the
three month value (Fig. 4a and Table 1) (P = 0.006 at
6 months, P = 0.003 at 1 year) were found, as well as a
significant postoperative subepithelial haze reduction
(P = 0.013 at 3 months, P = 0.001 at 6 months, P < 0.001
at 1 year compared to the preoperative value) (Fig. 4b
and Table 1). In Fig. 5 IVCM scans of subepithelial haze
and interface haze are shown.
Correlations between best corrected visual acuity and
other parameters
Even though graft thickness measured by AS-OCT and
BCVA at any follow-up stage were not significantly cor-
related (r = -0.08, r = -0.01, r = -0.28 respectively; P > 0.05
for all coefficients), a modest correlation between the
reduction of graft thickness and the improvement of
BCVA between month 6 and month 12 (r = 0.39, P = 0.049)
was observed.
There was a significant correlation between preoperative
subepithelial haze and BCVA at 3 and 6 months (r = 0.61,
P < 0.001 and r = 0.46, P = 0.002 respectively), while it was
Table 1 Descemet stripping automated endothelial keratoplasty: main outcome measures
Outcome measure Preoperative 3 months 6 months 1 year
BCVA (LogMAR) 0.78 (0.35) 0.28 (0.15)** 0.20 (0.11)** 0.14 (0.9)**
Graft Thickness (AS-OCT) (μm) 132.3 (32.7) 124.8 (34.0)* 117.8 (36.)** 111.0 (33.8)**
Graft Thickness (IVCM) (μm) NA 130.0 (35.2) 120.7 (36.7)* 114.7 (37.4)*
Subepithelial haze (LRU) 133.0 (34.3) 98.1 (48.0)* 82.8 (33.9)* 75.6 (32.1)**
Interface haze (LRU) NA 89.7 (49.3) 71.7 (37.1)* 68.8 (36.9)*
Results are expressed as mean (SD)
AS-OCT = Anterior segment optical coherence tomography
IVCM = In vivo confocal microscopy
LRU Light reflectance units
NA Not applicable
* = P <0.05 vs preoperative or 3-month (for graft thickness by IVCM and interface haze) value
** = P < 0.001 vs preoperative value or 3-month (for graft thickness by IVCM and interface haze) value
Fig. 2 Graft thickness up to 1-year follow-up after Descemet stripping automated endothelial keratoplasty, measured by anterior segment-OCT
(AS-OCT) and in vivo confocal microscopy (IVCM). a A statistically significant reduction of graft thickness measured by anterior segment-OCT compared
to the preoperative value (P = 0.022 at 3 months, p < 0.001 at 6 and 12 months) and to the 3-month value (P = 0.069 at 6 months, p < 0.001 at
12 months) was observed. Preoperative graft thickness was provided by the Eye bank. b Postoperative graft thickness measured by in vivo
confocal microscopy decreased significantly at 6 months and 1 year compared with the 3-month value (P = 0.026 and P = 0.003, respectively)
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no more significant at month 12 (r = 0.32, P = 0.068)
(Fig. 6a).
At 3 months and 6 months follow-up interface haze
and postoperative BCVA were significantly correlated
(r = 0.51, P < 0.001 at 3 months; r = 0.46, P = 0.003 at
6 months), whereas there was no correlation at 1 year
(r = 0.07, P = 0.69) (Fig. 6b).
At 3 months and 6 months we found a low even if
statistically significant correlation between postopera-
tive subepithelial haze and postoperative BCVA (r = 0.43,
P = 0.004 at 3 months; r = 0.39, P = 0.001 at 6 months)
(Fig. 6c), while at 1 year the correlation was not significant
(r = 0.26, P > 0.05).
A correlation between the decrease of subepithelial
haze and the improvement of BCVA between 6 months
and 3 months (r = 0.49, P > 0.001) and between 12 and
6 months (r = 0.40, P = 0.008) was also observed.
Finally, we checked whether the interval change in
BCVA at 3-6 months and 6–12 months was simultan-
eously related to that of graft thickness and subepithelial
and interface haze. This confirmed that an improvement
of BCVA was not associated with graft thickness change,
whereas a significant association was found with a re-
duction of subepithelial haze both at 3–to–6 (P = 0.017)
and at 6–to–12 months (P = 0.001). Interface haze
reduction positively affected BCVA at 6-to-12 months
(P = 0.013) only.
Discussion
Our series of DSAEK performed in pseudophakic pa-
tients affected by Fuchs’ corneal endothelial dystrophy
showed good results in terms of visual gain and postop-
erative corneal haze reduction. While we didn’t find any
influence of the graft central thickness on postoperative
BCVA, our analysis indicated a inverse correlation be-
tween subepithelial and donor-recipient interface haze
and visual outcome.
Several factors have been considered to affect post-
DSAEK visual outcome in clear grafts and in absence of
ocular comorbidities. First of all, graft thickness has been
hypothesized to negatively influence the visual gain after
DSAEK [9, 32], this being supported by the promising
initial results of new techniques such as DMEK [33, 34].
Fig. 4 Postoperative donor-recipient interface haze and subepithelial haze measured by in vivo confocal microscopy. a At every follow-up stage
donor recipient interface haze significantly decreased compared to the three month value (P = 0.006 at 6 months, P = 0.003 at 1 year). b Compared to
the preoperative value (month 0) the reduction of subepithelial haze was significant at any follow-up stage (P = 0.013 at 3 months, P = 0.001 at
6 months, P < 0.001 at 1 year). LRU: light reflectance units
Fig. 3 Graft thickness measured by AS-OCT 6 months after Descemet
stripping automated endothelial keratoplasty. Central graft thickness
(93 μ) was measured on a horizontal cross sectional image
obtained at the corneal vertex, using the software-imbedded
flap-tool (high-resolution corneal scan mode)
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DMEK includes the implantation of thin grafts, composed
only of Descemet membrane and endothelium, without
donor stroma remnants. A discussion is still ongoing on
this subject: many authors did not find any influence of a
preoperative [20] or postoperative [17, 18, 21, 25, 35]
thicker graft on postoperative BCVA. Even if we ob-
served a statistically significant reduction of graft
thickness during the 1 year follow-up, our results
showed no correlation between visual outcome and
postoperative central graft thickness, that was mea-
sured by both AS-OCT and IVCM.
Since to our best knowledge reports about a possible
correspondence between the pachymetric measurements
of the AS-OCT Visante and the IVCM Confoscan 4 are
lacking, we report for the first time a good correlation
between the graft thickness obtained by the two instru-
ments, suggesting that IVCM can be considered a reliable
instrument also for pachymetric measurements [31].
It has been reported [9, 14, 32] that other characteristics
of the endothelial graft, such as the often not uniform
thickness and the asymmetry of the graft, may more nega-
tively affect the visual outcome after DSAEK. Graft pre-
pared by a microkeratome often shows uneven thickness,
with the center thinner than the periphery, and/or asym-
metry: these factors are considered the main cause of the
hyperopic shift observed after DSAEK and of posterior
corneal high-order aberrations respectively [10, 32].
Another important factor that has been considered in
affecting BCVA after DSAEK is corneal haze (or
backscatter), that can be mainly located in the sube-
pithelial region and in the graft-host stromal interface
[22, 30, 36].
The subepithelial haze is a common finding to several
corneal abnormalities, such as Fuchs’ endothelial dys-
trophy or other chronic endothelial dysfunction, and it
has been related to tissue changes such as fibrosis caused
by chronic edema [28, 36]; together with interface haze, it
has been considered an expression of wound healing re-
sponse that includes keratocyte activation and stromal
extracellular matrix remodeling [30]. It has been demon-
strated that it can persist for years after DSAEK, even
though slowly decreasing, and the amount of both pre-
operative and postoperative haze has been related to low
visual outcome after DSAEK [36]. The real clinical impact
of subepithelial haze, whether it can affect visual acuity,
visual quality or both it is still not clear: while some au-
thors state that BCVA can be affected by subepithelial
haze [22], others found no correlation with the visual acu-
ity but only with visual quality in terms of forward light
scatter or glare disability [23].
In our study we found a correlation between preopera-
tive subepithelial haze and BCVA at 3 and 6 month
follow-up, and between postoperative subepithelial haze
and BCVA at the same visits. We found also a correl-
ation between the change of postoperative subepithelial
haze and that of BCVA between 6 months and 3 months
and between 12 and 6 months, suggesting that it can be
an important factor limiting DSAEK visual outcome.
Since the preoperative subepithelial haze can affect
postoperative visual outcome (directly or causing more
postoperative subepithelial haze), and a correlation between
the amount of the subepithelial haze with the duration and
the severity of corneal edema in the host cornea before sur-
gery and between patients’ age and visual outcome has
Fig. 5 Confoscan images of the corneal subepithelial haze and the donor-recipient interface haze 6 months after Descemet stripping automated
endothelial keratoplasty (DSAEK). a Corneal subepithelial scan, showing activated keratocytes and probably fibroblast. b Confoscan graph show
the characteristic peaks of reflectivity that can be noted after DSAEK: from left to right the endothelial peak, the donor-recipient interface peak,
the subepithelial and the epithelial peak. The cursor (vertical green line), corresponding to image (A), is located at the subepithelial reflectivity
peak. c Graft interface scan of the same patient at the same visit. d Confoscan graph indicating the position of the scan (C), at the donor-recipient
interface reflectivity peak
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been found [23, 36], we agree with the hypothesis that
could be crucial to perform DSAEK earlier in the natural
history of the disease, possibly reducing the duration and
the amount of the subepithelial fibrosis, before it become
irreversible [23, 36].
Also donor-recipient interface haze has been assumed
to affect visual outcome after endothelial keratoplasty
[13, 37, 38]; in contrast Espana et al [30] and Baratz et al
[23] did not find a significant correlation between
interface reflectivity and visual outcome. Our data show
a correlation between interface haze and postoperative
BCVA at 3 and 6 month follow-up, whereas considering
the interval changes interface haze reduction positively
affected BCVA at 6-to-12 months only.
Several instruments has been recently used to measure
corneal haze or backscatter, such as Scheimpflug Camera
[10, 37] and AS-OCT [12]. Confoscan 4 IVCM, even if it
may be more operator-dependent in comparison with
other instruments and may require more patient compli-
ance in order to obtain good quality scans and reproducible
measurements, allows to assess in the same examination
the characteristics of all the corneal layers at a cellular level
and to correlate the scan peak representing corneal haze
with cellular and tissutal alterations, giving more pre-
cise indication of their location. It can also perform cell
count and, as previously stated, pachymetric measure-
ments. It can provide quantitative information about
corneal haze while giving an inner vision of the corneal
tissue, useful in postoperative evaluation after corneal
transplant. Drawbacks of this technique could be the
small dimension of the area analyzed and the lack of a
overall view of the cornea.
Conclusions
Our study confirmed the subepithelial haze and the
interface haze as important factors limiting visual acuity
after DSAEK, while central graft thickness was not re-
lated to BCVA. No correlation between these parameters
was found at 1 postoperative year, maybe due to the re-
duced range of visual acuity reached after the gradual
improvement observed during the follow-up and to the
limited number of patients.
Limitations of our study are the lack of the aberro-
metric evaluation of postoperative quality of vision and
the short follow-up.
Further larger studies are necessary to investigate the
role of corneal haze and other parameters in affecting
not only visual acuity but also visual quality after
DSAEK, and to assess their impact in patients’ quality of
life after DSAEK.
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